Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
News Topics
- (-) Isotopes (13)
- 3-D Printing/Advanced Manufacturing (25)
- Advanced Reactors (11)
- Artificial Intelligence (21)
- Big Data (7)
- Bioenergy (14)
- Biology (8)
- Biomedical (8)
- Biotechnology (1)
- Buildings (6)
- Chemical Sciences (32)
- Clean Water (3)
- Climate Change (9)
- Composites (9)
- Computer Science (35)
- Coronavirus (6)
- Critical Materials (13)
- Cybersecurity (21)
- Decarbonization (9)
- Energy Storage (35)
- Environment (20)
- Exascale Computing (2)
- Frontier (4)
- Fusion (19)
- Grid (11)
- High-Performance Computing (8)
- Irradiation (1)
- ITER (1)
- Machine Learning (16)
- Materials (74)
- Materials Science (78)
- Mathematics (1)
- Microscopy (27)
- Molten Salt (3)
- Nanotechnology (39)
- National Security (35)
- Net Zero (1)
- Neutron Science (35)
- Nuclear Energy (28)
- Partnerships (15)
- Physics (29)
- Polymers (17)
- Quantum Computing (3)
- Quantum Science (12)
- Renewable Energy (1)
- Security (11)
- Simulation (2)
- Space Exploration (2)
- Summit (5)
- Sustainable Energy (17)
- Transformational Challenge Reactor (3)
- Transportation (16)
Media Contacts
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
“Made in the USA.” That can now be said of the radioactive isotope molybdenum-99 (Mo-99), last made in the United States in the late 1980s. Its short-lived decay product, technetium-99m (Tc-99m), is the most widely used radioisotope in medical diagnostic imaging. Tc-99m is best known ...